| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |